|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: IDEC PHARMACEUTICALS CORP / DE, 10-Q, EX-10.12, 2000-11-03 |
Next: IDEC PHARMACEUTICALS CORP / DE, S-3, 2000-11-03 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEETS AND CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS FOR THE YEAR ENDED SEPTEMBER 30, 2000 CONTAINED IN THE COMPANY'S
QUARTERLY REPORT ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIALS STATEMENTS AND THE NOTES THERETO.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 96,857
<SECURITIES> 178,126
<RECEIVABLES> 1,611
<ALLOWANCES> 212
<INVENTORY> 212
<CURRENT-ASSETS> 318,927
<PP&E> 69,811
<DEPRECIATION> 24,009
<TOTAL-ASSETS> 382,631
<CURRENT-LIABILITIES> 20,375
<BONDS> 0
0
0
<COMMON> 22
<OTHER-SE> 225,465
<TOTAL-LIABILITY-AND-EQUITY> 382,631
<SALES> 0
<TOTAL-REVENUES> 103,965
<CGS> 0
<TOTAL-COSTS> 51,902
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 5,293
<INCOME-PRETAX> 39,863
<INCOME-TAX> 6,889
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 32,974
<EPS-BASIC> 0.74
<EPS-DILUTED> 0.63
</TABLE>
|
|